Dudediligence.

Solventum Corporation

SOLVNYSE · Surgical & Medical Instruments & Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$2.08BSep ’24$2.08BDec ’24$2.07BMar ’25$2.16BJun ’25$2.10BSep ’25$2.00BDec ’25$2.01BMar ’26$2.21BJun ’26
Net income, by quarter
$122.0MSep ’24$31.0MDec ’24$137.0MMar ’25$90.0MJun ’25$1.27BSep ’25$63.0MDec ’25$13.0MMar ’26$92.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$8.13B$8.20B$8.25B$8.32B
Gross profitnone on file$4.70B$4.69B$4.59B$4.45B
Operating incomenone on file$1.69B$1.69B$1.04B$2.18B
Net incomenone on file$1.34B$1.35B$479.0M$1.56B
Operating cash flownone on file$1.68B$1.92B$1.19B$369.0M
Free cash flownone on file$1.43B$1.63B$805.0M−$10.0M
Cash$91.0M$61.0M$194.0M$762.0M$878.0M
Debtnone on filenone on file$0.00$8.01B$5.04B
Shares outstandingnone on file172.7M0172.8M173.5M